Setting 
My Cart
Toggle Nav
Close
  • Menu
  • Setting

GPCR/G protein

G-protein-coupled receptors (GPCRs) mediate a wide range of physiological responses to environmental stimulants, neurotransmitters, hormones cytokines and lipid signaling molecules. As a result, GPCRs play a significant role in biological processes such as vision, olfaction, the autonomic nervous system, and behavior.

All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.

GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.

Items 1321-1330 of 1407

Page
per page
  1. NTP42
    BA5701 NTP42
    Summary: NTP42 is a thromboxane receptor antagonist that antagonizes TP-mediated [Ca] circulation after stimulation of cells with the prostaglandin receptor (TP) agonist U46619 with an IC of 3.278 nM.
  2. Ricinoleic Acid
    C4955 Ricinoleic Acid
    Summary: A hydroxy fatty acid raw material used for the preparation of lubricants, cosmetics, polymers, and coatings.
      ≤20 mg/mL
  3. PD 168368
    C5142 PD 168368
    Summary: A selective NMB-R antagonist and an agonist of the FPR family receptors.
      ≤30 mg/mL
  4. AR420626
    C5514 AR420626
    Summary: An FFAR3 agonist with anti-inflammatory, anticancer, and metabolic abnormality-improving effects.
      ≥34.1 mg/mL
  5. Diphenhydramine
    BA1265 Diphenhydramine
    Summary: Diphenhydramine is a first-generation histamine H1 receptor antagonist with anticholinergic activity.
      ≥48.5 mg/mL
  6. Ranitidine
    BA1524 Ranitidine
    Summary: Ranitidine is an effective, selective, orally active histamine H2 receptor antagonist.
      ≥52.6 mg/mL
  7. Trazodone
    BA5017 Trazodone
    Summary: Trazodone (AF-1161 freebase) is a serotonin receptor antagonist and reuptake inhibitor.
      ≥25.25 mg/mL
  8. DCOIT
    BA5361 DCOIT
    Summary: DCOIT is a representative isothiazolinone that can stimulate the synthesis of follicle-stimulating hormone and luteinizing hormone in the brain mediated by gonadotropin-releasing hormone receptor.
      ≥48.6 mg/mL
  9. Clopidogrel
    BA5681 Clopidogrel
    Summary: Clopidogrel is a receptor-targeted, orally active platelet inhibitor.
      ≥57.8 mg/mL
  10. Tyloxapol
    BA9536 Tyloxapol
    Summary: Tyloxapol (TritonWR1339) is an alkyl aryl polyether alcohol-type nonionic liquid polymer, used as a surfactant stabilizer.
      ≥50.2 mg/mL

Items 1321-1330 of 1407

Page
per page